New treatment modality for amyloidosis related diseases – Vermilion Therapeutics

Developing a promising therapeutic technology which may contribute to treat various amyloidosis related diseases, incl. Alzheimer’s Disease.

Venture Valuation (VV) interviewed TORII Shin-ichi, Ph.D., founder and CEO.

Read the Interview

Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?